HAGAN JOSEPH P (President and CEO) received a stock award from REGULUS THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/10/2025ACC: 0000950170-25-004274
DirectorOfficer· President and CEO
Since Feb 2019
+280.75K
Net shares
Net buyer
$378.1K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
280.75K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+218.75K
Price / share
$1.36
Trade value
$297.50K
% of position
383.0%
1/9/2025
57.11K→275.86K
Common Stock
Direct
Shares
+62K
Price / share
$1.30
Trade value
$80.60K
% of position
22.5%
1/9/2025
275.86K→337.86K
Total
Net shares
+280.75K
Net value
$378.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2025 | A · Award | +218.75K | $1.36 | $297.50K | 383.0% | 57.11K | 275.86K |
| Common Stock Direct | 1/9/2025 | A · Award | +62K | $1.30 | $80.60K | 22.5% | 275.86K | 337.86K |
| Total | +280.75K | $378.10K | ||||||
Derivative Transactions0
No derivative transactions reported